- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 16th, 2007
The Wall Street Transcript has published an in-depth interview with Stephen M. Simes, president and CEO of BioSante Pharmaceuticals, Inc. (AMEX:BPA) in which he talks at length about the Company.
The entire 2,500 word interview is available free online at http://www.twst.com/ceos.htm.
BioSante is developing a pipeline of hormone therapy products to treat both men and women. BioSante's hormone therapy products are gel formulations for transdermal administration that deliver bioidentical estradiol and testosterone. The company also is developing its calcium phosphate nanotechnology (CaP) for novel vaccines, including avian flu and biodefense vaccines for toxins such as anthrax, and drug delivery systems.
|Related News Press|
50 years after the release of the film 'Fantastic Voyage,' science upstages fiction: Science upstages fiction with nanorobotic agents designed to travel in the human body to treat cancer August 25th, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Down to the wire: ONR researchers and new bacteria August 18th, 2016
Hexagonal boron nitride semiconductors enable cost-effective detection of neutron signals: Texas Tech University researchers demonstrate hexagonal boron nitride semiconductors as a cost-effective alternative for inspecting overseas cargo containers entering US ports August 17th, 2016
'Second skin' protects soldiers from biological and chemical agents August 5th, 2016
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016